NCT Heidelberg
NCT Heidelberg is a joint academic cancer center in Heidelberg, Germany, providing comprehensive oncology care, translational research, and medical education across 20+ specialized outpatient clinics, serving cancer patients, referring physicians, and medical trainees.
- Company typePrivate
- Founded2004
- HeadquartersHeidelberg, Germany
- Headcount101–250
- GTM typeB2C
- OfferingServices
What NCT Heidelberg does
NCT Heidelberg is a joint academic cancer center established in 2004 in Heidelberg, Germany, operated collaboratively by the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), Heidelberg University Medical Faculty, and Thoraxklinik Heidelberg. The center provides comprehensive oncology care across more than 20 specialized outpatient clinics covering major tumor types, integrating radiation therapy, medication therapy, immunotherapy, surgery, and clinical trial enrollment. It is designated an Oncology Center of Excellence (Onkologisches Spitzenzentrum) by Deutsche Krebshilfe.
NCT Heidelberg firmographics
Firmographics- Name
- NCT Heidelberg
- Legal name
- National Center for Tumor Diseases (NCT) Heidelberg
- Website
- https://nct-heidelberg.de
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- NCT Heidelberg is a joint academic cancer center in Heidelberg, Germany, providing comprehensive oncology care, translational research, and medical education across 20+ specialized outpatient clinics, serving cancer patients, referring physicians, and medical trainees.
- Ownership category
- akta.pro rank
NCT Heidelberg industry classification
Industry- Product category
- Oncology Services
- NAICS
- Medical Laboratories (621511), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), General Medical and Surgical Hospitals (62211)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Medical Oncology (HLAKAFAB)
Keywords
Where NCT Heidelberg is headquartered
LocationHeadquarters
- HQ city
- Heidelberg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
NCT Heidelberg business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Healthcare Service Reimbursement: Reimbursement through German public health insurance system (GKV/PKV) for covered medical treatments including radiation therapy, medication therapy, surgery, and clinical care.
- Research Grants and Funding: Funding from German federal and state agencies including BMBF, DFG, as well as foundations such as Dietmar Hopp Stiftung, Deutsche Krebshilfe (DKH), and other cancer research funding bodies.
- Donations and Charitable Contributions: Accepts donations through various channels including bank transfer, personal fundraising campaigns, memorial donations, bequests, and charity shopping. Benefits from charity events including NCT-Lauf (Run), Rudern gegen Krebs (Rowing), and Takte gegen Krebs (Music concerts).
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
NCT Heidelberg product offering
Product offeringCore offering
NCT Heidelberg is a comprehensive cancer center providing integrated cancer diagnosis, treatment, and research services. It offers multimodal therapy including radiation therapy, medication therapy, surgery, and immunotherapy, supported by molecular precision oncology through the MASTER program. The center also delivers supportive care (psycho-oncology, nutrition, palliative care), clinical trial access, and medical education programs.
Product overview
NCT Heidelberg is a comprehensive cancer center offering integrated cancer treatment, research, and education services. The institution provides a full spectrum of treatment services including radiation therapy, medication therapy, immunotherapy, surgery, and clinical trials. Support services encompass physical activity programs (Netzwerk OnkoAktiv), nutrition counseling, psycho-oncology, palliative care, and social services. The research division includes Molecular Precision Oncology programs (MASTER, NCT POP), Core Services (Clinical Trial Center, Sample Processing Lab, Tissue Bank, Cancer Registry), and various specialized research areas. Education programs include the Elective Track Interdisciplinary Oncology, Fellowship Program, NCT Masterclass, and Practical Year rotations for medical students. Treatment is organized across multiple specialized cancer centers including Breast Cancer Center, Gynecological Oncology, Skin Tumor Center, Pediatric Oncology, Head Neck Cancer, Lung Cancer, Prostate Cancer, Sarcoma, Visceral Oncology (Colorectal, Stomach, Liver, Pancreatic, Esophageal), and Hematologic Neoplasms.
Differentiator
Problem solved
Functional benefit
Brands
- Netzwerk OnkoAktiv: Network for physical activity and exercise therapy for cancer patients
- NCT Cancer Registry
- MASTER Program
- Sozietät Czerny
Products and services
- Radiation Therapy Radiation oncology treatment services delivered as part of the comprehensive cancer care offerings for adult and pediatric oncology patients.
- Medication Therapy Medication-based cancer treatment services including chemotherapy and targeted therapies for oncology patients.
- Immunotherapy Immunotherapy treatment services offered to cancer patients as part of the multimodal treatment portfolio.
- Surgical Oncology Cancer surgery services performed within Heidelberg University Hospital departments in coordination with NCT Heidelberg.
- Clinical Trials Enrollment and conduct of oncology clinical trials spanning all phases, providing patients access to experimental and translational treatments.
- Multidisciplinary Tumor Board Multidisciplinary team review of individual patient cases for comprehensive treatment planning across oncology specialties.
- MASTER Molecular Precision Oncology Program Comprehensive molecular profiling program analyzing tumor genomes to guide personalized treatment decisions, including NCT POP for clinical translation of molecular findings.
- Netzwerk OnkoAktiv Exercise Therapy Germany-wide network of exercise therapy and physical activity programs for cancer patients, coordinated by NCT Heidelberg with partner facilities.
- Psycho-Oncology Service Psychological counseling and support services for cancer patients and their families during and after treatment.
- Palliative Medicine Palliative medicine and end-of-life care services for patients with advanced cancer diagnoses.
- Nutrition Counseling Nutritional counseling and dietary support services tailored for cancer patients during treatment and recovery.
- Smoking Consultation (Rauchersprechstunde)
Companies that use NCT Heidelberg
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
NCT Heidelberg technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
NCT Heidelberg partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- German Cancer Research Center (DKFZ)coreDKFZ is the national research center for cancer in Germany and serves as a primary supporting institution of NCT Heidelberg. Provides research infrastructure, scientific expertise, and translational research capabilities. The NCT was established as a joint institution with DKFZ as a founding partner alongside UKHD, Heidelberg University, and Thoraxklinik Heidelberg.
- Heidelberg University Hospital (UKHD)coreUKHD is the clinical care partner in the NCT Heidelberg joint institution. Provides hospital facilities, clinical staff, and patient care infrastructure. Major clinical rotations for NCT programs occur in UKHD departments including Hematology, Radiooncology, and Internal Medicine.
- Heidelberg University (Universität Heidelberg)coreThe Medical Faculty of Heidelberg University participates as a supporting institution, contributing academic research capabilities and medical education programs including the HeiCuMed medical curriculum and the Wahlfachtrack Interdisciplinary Oncology elective program.
- Thoraxklinik HeidelbergcoreSpecialized thoracic oncology clinic serves as a partner institution for lung cancer treatment and research. Clinical rotations for NCT students and fellows include time at the Thoraxklinik for thoracic oncology experience.
- RocheminorIndustrial collaboration between NCT Heidelberg and Roche focusing on pharmaceutical research and development in oncology. Part of NCT's industrial partnership program for translational cancer research.
- Cancer Core EuropeminorEuropean cancer research network connecting major European cancer centers for collaborative research, data sharing, and clinical trial coordination. NCT Heidelberg participates as a member institution in this international partnership.
- Sozietät CzernyminorHeidelberg Medical Faculty consortium for interdisciplinary medical education. NCT draws on existing structures of Sozietät Czerny for elective track courses in oncology. Czerny society members can participate in NCT elective courses.
- Network OnkoAktivminorGermany-wide network of exercise therapy and physical activity programs for cancer patients. NCT Heidelberg coordinates the network, which includes multiple cooperation centers across Germany delivering exercise oncology services to patients.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
NCT Heidelberg competitors and assessment
Company assessmentBroad incumbents
- European Institute of Oncology (IEO): IEO in Milan is one of Europe's largest standalone oncology institutions, offering similar precision medicine, surgery, and clinical research. It is a broader incumbent peer with comparable European footprint and academic medical center positioning.
- MD Anderson Cancer Center: MD Anderson is the global benchmark for comprehensive cancer centers with a comparable research-clinical integration model. While much larger and US-based, it represents the architectural incumbent peer that NCT Heidelberg's MASTER and translational programs are benchmarked against.
Direct peers
- Netherlands Cancer Institute (NKI): NKI is a leading European comprehensive cancer center with similar translational research, molecular profiling, and clinical trial programs. It is a direct peer within Cancer Core Europe for cross-border research collaboration and competitive clinical trial activation.
- Gustave Roussy Institute: Gustave Roussy is France's leading comprehensive cancer center and a fellow Cancer Core Europe member. It directly peers with NCT Heidelberg on cross-border precision oncology trials, virotherapy research, and pan-European clinical trial leadership.
- Charité Comprehensive Cancer Center: Charité's CCC in Berlin is one of Germany's leading comprehensive cancer centers, with similar precision oncology programs, clinical trial infrastructure, and DKFZ-affiliated research. It directly competes with NCT Heidelberg for national oncology leadership, pharma-sponsored trials, and top clinical talent.
- Vall d'Hebron Institute of Oncology (VHIO): VHIO is a leading Spanish comprehensive cancer center and a Cancer Core Europe member, with parallel precision oncology, early-phase trial, and translational research programs. It is a direct European peer competing for pharma-sponsored trial activation and molecular diagnostics leadership.
- LMU Klinikum – Comprehensive Cancer Center Munich: Munich's CCC (LMU/TU Munich) operates molecular precision oncology, immunotherapy, and comprehensive outpatient clinics similar to NCT Heidelberg. It is a direct peer for clinical trial leadership, precision oncology program development, and southern German patient referrals.
- University Hospital Tübingen – CCC Tübingen-Stuttgart: The Tübingen-Stuttgart CCC is a Baden-Württemberg-based comprehensive cancer center in the same German state as NCT Heidelberg. It directly competes for southern German patient referrals and DKH funding for precision oncology and translational programs.
- UCT Frankfurt (University Cancer Center Frankfurt): UCT Frankfurt is a designated Oncology Center of Excellence with comparable multidisciplinary tumor boards, molecular diagnostics, and translational research programs. It serves as a direct national peer competing for hematology/oncology referrals, trial patients, and research funding.
- Karolinska Comprehensive Cancer Center: Karolinska CCC in Stockholm is a fellow Cancer Core Europe member with comparable precision oncology and translational research programs. It directly peers with NCT Heidelberg on Nordic–Central European trial collaboration and oncology research leadership.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
NCT Heidelberg social profiles
Digital presenceNCT Heidelberg financial estimates
Financial estimateRevenue estimate
Valuation estimate
NCT Heidelberg leadership team
Management profileNumber of profiles
Profiles6 records
NCT Heidelberg funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NCT Heidelberg M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NCT Heidelberg
What does NCT Heidelberg do?
NCT Heidelberg is a comprehensive cancer center providing integrated cancer diagnosis, treatment, and research services. It offers multimodal therapy including radiation therapy, medication therapy, surgery, and immunotherapy, supported by molecular precision oncology through the MASTER program. The center also delivers supportive care (psycho-oncology, nutrition, palliative care), clinical trial access, and medical education programs.
Is NCT Heidelberg a public or private company?
NCT Heidelberg is a private company. It is classified as state government owned and is currently operating.
When was NCT Heidelberg founded?
NCT Heidelberg was founded in 2004. It employs 101 to 250 people.
Where is NCT Heidelberg based?
NCT Heidelberg is headquartered in Heidelberg, Germany, in the Europe region.
How does NCT Heidelberg make money?
Three revenue lines are on record. Healthcare Service Reimbursement is the primary driver. The others are research Grants and Funding and donations and Charitable Contributions.
Who are NCT Heidelberg's main competitors?
Broad incumbents on record are European Institute of Oncology (IEO) and MD Anderson Cancer Center. Direct peers are Netherlands Cancer Institute (NKI), Gustave Roussy Institute, Charité Comprehensive Cancer Center, Vall d'Hebron Institute of Oncology (VHIO), LMU Klinikum – Comprehensive Cancer Center Munich, University Hospital Tübingen – CCC Tübingen-Stuttgart, UCT Frankfurt (University Cancer Center Frankfurt) and Karolinska Comprehensive Cancer Center.
Does NCT Heidelberg have an API?
No public API is recorded for NCT Heidelberg.
What industry is NCT Heidelberg in?
NCT Heidelberg's product category is Oncology Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 621511 and its SIC code is 8093.